#ALBENDAZOLE IP API

[dolphinpharmamanufacturer]

What are the regulatory approvals for Dolphin Pharma’s Albendazole API

Dolphin Pharma’s Albendazole API is manufactured in facilities that comply with WHO-GMP, FDA, and DCGI regulations, ensuring global acceptance and compliance with pharmaceutical industry standards. Our API meets USP, BP, EP, and IP specifications, making it suitable for pharmaceutical formulations worldwide. We follow strict quality control measures, stability testing, and regulatory documentation to ensure compliance with international guidelines. Our R&D team continuously innovates to improve API quality and efficiency, ensuring that our customers receive the best products. Dolphin Pharma is a trusted Albendazole API supplier and exporter, serving the needs of leading pharmaceutical companies across 90+ countries.

[techsuvichar]

Earum IPO Date, Price, GMP, Review & Details

Earum IPO Date, Price, GMP, Review & Details

Incorporated in 2012, Ahmedabad-based Earum Pharmaceuticals Limited is engaged in trading, marketing, distribution of pharmaceutical formulation products. The company has 125 drugs formulation products including multivitamins, gynecology drugs, steroids, anti-biotic drugs, cerebral activator drugs, gastrointestinal drugs, etc. The company is also involved in the trading business of active pharmaceutical ingredients (API's) including Amoxicillin Trihydrate IP, Levofloxacin Hemihydrate IP, and Albendazole IP. Earum Pharmaceuticals is primarily engaged in two types of business activities; marketing of its own formulations products and trading of other brands' generic formulations. Currently, it has around 24 products which are manufactured by 3rd parties and marketed by the company under its brand name.It has a warehouse at Ahmedabad, Gujarat equipped with all amenities to process business operations smoothly. The company has a domestic and international presence across South East Asia, Latin America, and Africa. Future goals of Earum Pharmaceuticals Ltd are: 1. Make global presence more prominent 2. Enhance customer satisfaction by improving market skills 3. Deal in quality standard products

The competitive strengths of the company are: 1. Wide product range 2. The experienced promoter of 11+ years experience 3. Quality assurance

Company Promoters: Mr. Bhumishth Narendrabhai Patel and Mrs. Payal Bhumishth Patel are the promoters of the company.

Company Financials: Summary of financial Information (Restated) Particulars For the year/perio(d/d eefnadueltd.a s(pin) Rs. Lakhs) 31-Dec-18 31-Mar-18 31-Dec-17 31-Mar-16 Total Assets 2,741.00 2,052.88 1,108.45 878.71 Total Revenue 3,449.85 3,543.67 2,333.95 1,856.66 Profit After Tax 86.51 85.65 15.98 9.76

Objects of the Issue: The company intends to utilize the proceeds of the Issue to meet the following objects:- 1. To meet Working Capital requirements 2. General Corporate Purpose 3. To meet issue expenses

Earum IPO Details Issue Open Jun 21, 2019 - Jun 26, 2019 Issue Type Fixed Price Issue IPO Issue Size 1,848,000 Eq Shares of Rs 10 (aggregating up to Rs 6.65 Cr) Face Value Rs 10 Per Equity Share Issue Price Rs 36 Per Equity Share Market Lot 3000 Shares Min Order Quantity 3000 Shares Listing At BSE SME

Earum IPO Promoter Holding Pre Issue Share Holding 100% Post Issue Share Holding

Earum Pharmaceuticals Limited G1, Ground Floor, V R Complex, Near Sanathal Cross Road, SP Ring Road, Sanathal, Ahmedabad, Gujarat-382210, Phone: +91-79-48402525 Email: cs@earumpharma.com Website: http://www.earumpharma.com

Bigshare Services Pvt Ltd 1st Floor, Bharat Tin Works Building, Opp. Vasant Oasis,Makwana Road, Marol, Andheri(E), Mumbai - 400 059 Phone: +91-22-6263 8200 Email: ipo@bigshareonline.com Website: http://www.bigshareonline.com

Conclusion / Investment Strategy EPL does not own manufacturing unit and is engaged in trading activities only. The issue is fully priced. Third-party contract business raises concern. Currently, the pharma sector is not fancied by investors. Merchant Banker has an average track record. Considering all these, investors may skip this issue.

Latest Share Market News, Latest Share News, Latest Share Market Tips, Latest Share Market Videos, Latest Share Market News In Hindi, Latest Share Recommendations , Latest Stock Market News, Latest Stock Market Recommendations , Latest Stock Market News India, Latest Stock News India, Latest Stock Picks, Latest Stock Market Analysis  Market Watch, Latest Stock Market Videos